Fairview Hospital; Cleveland Clinic Cancer Center

Cleveland, Ohio 44111

0 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Transitional Cell, Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Neoplasms, Renal Cell Carcinoma

Studies at this site

• A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy — Stopped early
• A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection — Stopped early
• A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — Completed